MASS 908 Devices Inc.

Nasdaq 908devices.com


$ 8.51 $ 0.11 (1.31 %)    

Friday, 24-Oct-2025 15:59:56 EDT
QQQ $ 617.18 nm (nm)
DIA $ 472.05 $ 4.92 (1.05 %)
SPY $ 676.99 nm (nm)
TLT $ 91.35 nm (nm)
GLD $ 378.14 $ -1.27 (-0.34 %)
$ 8.51
$ 8.53
$ 8.06 x 1
$ 8.80 x 3
$ 8.44 - $ 8.76
$ 1.81 - $ 9.34
170,437
na
303.12M
$ 1.76
nm
TBD
na
na ($ 0.00)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 08-05-2025 06-30-2025 10-Q
2 05-13-2025 03-31-2025 10-Q
3 03-07-2025 01-01-1970 10-K
4 11-12-2024 09-30-2024 10-Q
5 08-06-2024 06-30-2024 10-Q
6 05-03-2024 03-31-2024 10-Q
7 03-08-2024 12-31-2023 10-K
8 11-07-2023 09-30-2023 10-Q
9 08-08-2023 06-30-2023 10-Q
10 05-09-2023 03-31-2023 10-Q
11 03-15-2023 12-31-2022 10-K
12 11-14-2022 09-30-2022 10-Q
13 08-09-2022 06-30-2022 10-Q
14 05-10-2022 03-31-2022 10-Q
15 03-11-2022 12-31-2021 10-K
16 11-04-2021 09-30-2021 10-Q
17 08-04-2021 06-30-2021 10-Q
18 05-13-2021 03-31-2021 10-Q
19 03-31-2021 12-31-2020 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 908-devices-sells-17-xplorir-units-to-us-marine-corps-for-hazardous-gas-detection

908 Devices Inc. (NASDAQ:MASS), a pioneer of purpose-built handheld devices for chemical analysis, announces that the United St...

 leerink-partners-upgrades-908-devices-to-outperform-announces-12-price-target

Leerink Partners analyst Puneet Souda upgrades 908 Devices (NASDAQ:MASS) from Market Perform to Outperform and announces $12...

 908-devices-raises-fy2025-sales-guidance-from-53000m-55000m-to-54000m-56000m-vs-54337m-est

908 Devices (NASDAQ:MASS) raises FY2025 sales outlook from $53.000 million-$55.000 million to $54.000 million-$56.000 million v...

 908-devices-q2-eps-036-misses-021-estimate-sales-1304m-beat-1217m-estimate

908 Devices (NASDAQ:MASS) reported quarterly losses of $(0.36) per share which missed the analyst consensus estimate of $(0.21)...

 908-devices-affirms-fy2025-sales-guidance-of-5300m-5500m-vs-5517m-est

2025 Guidance908 Devices continues to expect full year 2025 revenues from continuing operations of $53 million to $55 million, ...

 908-devices-expects-q1-revenue-from-cont-ops-to-be-at-least-115m-vs-74m-last-year-reflecting-reported-growth-of-about-55

At least 55% reported revenue growth from continuing operations compared to prior year908 Devices Inc. (NASDAQ:MASS), a core sm...

 908-devices-strategic-shift-desktop-sale-to-repligen-optimizes-future-growth

Repligen acquires 908 Devices' desktop portfolio for $70 million, enhancing its bioprocessing analytics. 908 Devices shifts...

 908-devices-q4-2024-adj-eps-027-beats-035-estimate

908 Devices (NASDAQ:MASS) reported quarterly losses of $(0.27) per share which beat the analyst consensus estimate of $(0.35) b...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION